Effects of photobiomodulation on colon cancer cell line HT29 according to mitochondria.

Colon cancer Mitochondrial dynamics Oncometabolite Photobiomodulation

Journal

Journal of photochemistry and photobiology. B, Biology
ISSN: 1873-2682
Titre abrégé: J Photochem Photobiol B
Pays: Switzerland
ID NLM: 8804966

Informations de publication

Date de publication:
27 Jun 2024
Historique:
received: 11 04 2024
revised: 11 06 2024
accepted: 25 06 2024
medline: 7 7 2024
pubmed: 7 7 2024
entrez: 6 7 2024
Statut: aheadofprint

Résumé

Although photobiomodulation therapy (PBMt) is available to alleviate post-operative side effects of malignant diseases, its application is still controversial due to some potential of cancer recurrence and occurrence of a secondary malignancy. We investigated effect of PBMt on mitochondrial function in HT29 colon cancer cells. HT29 cell proliferation was determined with MTT assay after PBMt. Immunofluorescent staining was performed to determine mitochondrial biogenesis and reactive oxygen species (ROS). Mitochondrial membrane potential was measured with Mitotracker. Western blotting was executed to determine expression of fission, fusion, UCP2, and cyclin B1 and D1 proteins. In vivo study was performed by subcutaneously inoculating cancer cells into nude mice and immunohistochemistry was done to determine expression of FIS1, MFN2, UCP2, and p-AKT. The proliferation and migration of HT29 cells reached maximum with PBMt (670 nm, light emitting diode, LED) at 2.0 J/cm Treatment with PBM using red light LED may induce proliferation and progression of HT29 cancer cells by increasing mitochondrial activity and fission.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
Although photobiomodulation therapy (PBMt) is available to alleviate post-operative side effects of malignant diseases, its application is still controversial due to some potential of cancer recurrence and occurrence of a secondary malignancy. We investigated effect of PBMt on mitochondrial function in HT29 colon cancer cells.
METHODS METHODS
HT29 cell proliferation was determined with MTT assay after PBMt. Immunofluorescent staining was performed to determine mitochondrial biogenesis and reactive oxygen species (ROS). Mitochondrial membrane potential was measured with Mitotracker. Western blotting was executed to determine expression of fission, fusion, UCP2, and cyclin B1 and D1 proteins. In vivo study was performed by subcutaneously inoculating cancer cells into nude mice and immunohistochemistry was done to determine expression of FIS1, MFN2, UCP2, and p-AKT.
RESULTS RESULTS
The proliferation and migration of HT29 cells reached maximum with PBMt (670 nm, light emitting diode, LED) at 2.0 J/cm
CONCLUSIONS CONCLUSIONS
Treatment with PBM using red light LED may induce proliferation and progression of HT29 cancer cells by increasing mitochondrial activity and fission.

Identifiants

pubmed: 38970968
pii: S1011-1344(24)00126-X
doi: 10.1016/j.jphotobiol.2024.112966
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112966

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Hiun Suk Chae reports financial support was provided by National Research Foundation of Korea. Hiun Suk Chae reports a relationship with National Research Foundation of Korea that includes: funding grants. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Kyung Jin Seo (KJ)

Department of Pathology, Uijongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Jung Hwan Yoon (JH)

Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Bom Yee Chung (BY)

Department of Internal Medicine, Uijongbu St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.

Hae Kyung Lee (HK)

Department of Laboratory Medicine, Uijongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Won Sang Park (WS)

Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Electronic address: wonsang@catholic.ac.kr.

Hiun Suk Chae (HS)

Department of Internal Medicine, Uijongbu St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea. Electronic address: chs@catholic.ac.kr.

Classifications MeSH